EnteroTrack

EnteroTrack is a clinical-stage, platform technology company that provides a simple yet comprehensive solution to monitor and screen for upper GI diseases, starting with Eosinophilic Esophagitis (EoE), in the office or home. Intended for clinicians and patients who need frequent monitoring of chronic upper gastrointestinal diseases and population-based screening for early GI cancers, the company’s patented EnteroTracker® represents a first-in-market device for pain- and risk-free GI mucosal biopsy for children and adults, without the need for sedation or advanced training. Having established a commercial foothold and initial revenues with its Esophageal String Test® for Eosinophilic Esophagitis (EoE), EnteroTrack seeks to expand its unique, pipeline sample-and-test concept into monitoring and screening for other diseases of the upper GI system.